Ardelyx Inc
NASDAQ: ardx
$1.25
USD
+$0.04
+3.31%
Prev Close
$1.21
Today's Open
$1.20
Volume
9.37M
Market Cap
140.93M
Day Range
52W Range
Overview
Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California.
Read moreCurrent Price
15 min delay
Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)
Insufficient Data
Ratios
Valuation Ratios
EPS (TTM)
-1.537
P/E Ratio
0
Price to Sales
15.24
Price to Book
2.021
Profit Ratios
Profit Margin
0.00%
EBITDA Margin
-907.84%
Net Profit Margin
-529.81%
ROA
-48.40%
Total Revenue
$10.88M
Net Profit
-$57.63M
EV to EBITDA
0.0055
EV to Revenue
8.14